We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+12.39%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$19.4B
AUM Growth
+$2.11B
(+12%)
Cap. Flow
+$90.4M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
53.93%
Holding
1,534
New
81
Increased
246
Reduced
456
Closed
138
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$105M |
| 2 |
Match Group
MTCH
|
+$77.8M |
| 3 |
NextEra Energy
NEE
|
+$64.3M |
| 4 |
Keysight
KEYS
|
+$62.4M |
| 5 |
AutoZone
AZO
|
+$56.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$82.5M |
| 2 |
Microsoft
MSFT
|
+$42.5M |
| 3 |
Apple
AAPL
|
+$38.2M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$27M |
| 5 |
Johnson & Johnson
JNJ
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.9% |
| 2 | Technology | 17.9% |
| 3 | Healthcare | 11.08% |
| 4 | Communication Services | 8.12% |
| 5 | Consumer Discretionary | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
201
DELISTED
Aerie Pharmaceuticals
AERI
| $5.63M | 0.03% |
478,366
-124,500
| -21% | -$1.52M |
|
202
Texas Instruments
TXN
$255B
| $5.62M | 0.03% |
39,332
-907
| -2% | -$123K |
|
203
Consolidated Water Co
CWCO
$469M
| $5.58M | 0.03% |
536,456
-21,270
| -4% | -$258K |
|
|
AGEN
204
Agenus
AGEN
$249M
| $5.56M | 0.03% |
70,877
+20,228
| +40% | +$1.57M |
|
|
PTVCB
205
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $5.56M | 0.03% |
423,341
+5,906
| +1% | +$84.7K |
|
|
AGFS
206
DELISTED
AgroFresh Solutions Inc
AGFS
| $5.51M | 0.03% |
2,269,061
+7,050
| +0.3% | +$17.6K |
|
207
NiSource
NI
$22.4B
| $5.5M | 0.03% |
249,895
+257
| +0.1% | +$5.96K |
|
|
MAGN
208
Magnera Corp
MAGN
$488M
| $5.43M | 0.03% |
30,360
+262
| +0.9% | +$52.3K |
|
209
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.85B
| $5.42M | 0.03% |
101,984
+1,800
| +2% | +$98K |
|
210
Portland General Electric
POR
$6.02B
| $5.41M | 0.03% |
152,493
-12
| -0% | -$480 |
|
211
Automatic Data Processing
ADP
$100B
| $5.38M | 0.03% |
38,542
-6,775
| -15% | -$949K |
|
|
WBA
212
DELISTED
Walgreens Boots Alliance
WBA
| $5.38M | 0.03% |
149,638
-384
| -0.3% | -$15K |
|
213
Idacorp
IDA
$8.23B
| $5.24M | 0.03% |
65,559
+2,068
| +3% | +$182K |
|
|
KRTX
214
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $5.17M | 0.03% |
66,836
+30,300
| +83% | +$2.58M |
|
215
Xylem
XYL
$28.5B
| $5.08M | 0.03% |
60,415
+27
| +0% | +$2.1K |
|
|
CNST
216
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $5.07M | 0.03% |
+250,400
| New | +$6.11M |
|
|
GRA
217
DELISTED
W.R. Grace & Co.
GRA
| $5M | 0.03% |
123,982
+52,739
| +74% | +$2.4M |
|
218
General Mills
GIS
$19.2B
| $4.99M | 0.03% |
80,855
-286
| -0.4% | -$17.9K |
|
219
Bristol-Myers Squibb
BMY
$127B
| $4.96M | 0.03% |
82,303
-5,090
| -6% | -$306K |
|
220
Orion
OEC
$394M
| $4.96M | 0.03% |
396,150
+16,375
| +4% | +$196K |
|
221
Alibaba
BABA
$269B
| $4.94M | 0.03% |
16,805
+1,295
| +8% | +$341K |
|
222
Globe Life
GL
$13.5B
| $4.88M | 0.03% |
61,115
-4,152
| -6% | -$331K |
|
223
Enterprise Products Partners
EPD
$83.8B
| $4.86M | 0.03% |
307,632
-9,522
| -3% | -$167K |
|
224
Chesapeake Utilities
CPK
$3.26B
| $4.73M | 0.02% |
56,107
-66
| -0.1% | -$5.45K |
|
225
Ameriprise Financial
AMP
$46.8B
| $4.46M | 0.02% |
28,909
-1,485
| -5% | -$229K |
|
Similar funds
SAM
First Manhattan's Q3 2020 Portfolio in Review
As of Q3 2020, First Manhattan held 1,534 positions worth $19.4B, up 12% from $17.3B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
First Manhattan's Q3 2020 filing shows 81 new, 246 increased, 456 reduced and 138 closed positions. Its largest new stake was Constellation Pharmaceuticals, Inc.: 250,400 shares worth $5.07M. The largest sale was People Inc, an estimated $82.5M.
By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 38% a quarter earlier, followed by Technology and Healthcare.
- First Manhattan's largest Q3 2020 buy was Constellation Pharmaceuticals, Inc.: 250,400 shares worth $5.07M.
- First Manhattan added most to UnitedHealth in Q3 2020, an estimated $105M increase.
- First Manhattan's biggest Q3 2020 reduction was People Inc, cutting an estimated $82.5M.
- First Manhattan fully exited Aimmune Therapeutics in Q3 2020, selling an estimated $17.1M.
- First Manhattan's ten largest holdings make up 54% of its $19.4B portfolio in Q3 2020.
- First Manhattan opened 81 new positions and closed 138 in Q3 2020.
- First Manhattan's portfolio value rose 12% quarter-over-quarter to $19.4B.
Based on First Manhattan's 13F filing for Q3 2020, filed 12 Nov 2020.